Where will the TEVA (TEVA) stock price close on June 30, 2008?

U.S. court granted a request that would give Teva Pharmaceutical Industries Ltd (Israeli company) 180 days of exclusivity selling a generic version of widely used schizophrenia drug Risperdal. Johnson & Johnson's Risperdal, which is also approved to treat bipolar mania, had U.S. sales of about $2.5 billion in 2007.
JPMorgan analyst Adam Greene said "We project Teva could record around $230 million (in sales) during its exclusivity period".

Teva expects final approval with exclusivity on June 29.